A Baltimore mother says a quick decision by her pediatrician and a perfect sibling match at Johns Hopkins saved her five year ...
Personalized treatment strategies are increasingly important in managing lung cancer brain metastases, incorporating targeted therapies and immunotherapies. Stereotactic radiosurgery and whole-brain ...
WILLOW GROVE, Pennsylvania (WPVI) -- A Montgomery County community is rallying around a woman who is desperately searching for a blood stem cell donor. Yolanda Lee of Willow Grove is battling a ...
Infection was a leading cause of death in lower-risk myelodysplastic syndromes (MDS), highlighting the need for vigilant monitoring and preventive strategies. While research has focused on risk ...
MILAN — Immune-based treatments continue to fall short in myelodysplastic syndromes (MDS). Now, experts from the European Hematology Association’s (EHA) Specialized Working Group on MDS here at the ...
Most patients with high-risk myelodysplastic syndromes (MDS) do not receive guideline-recommended treatment with hypomethylating agents (HMAs), according to results published in Blood Neoplasia. The ...
Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, announces that ...
In patients with high-risk myelodysplastic syndromes, hypomethylating agents are underutilized, particularly among older, female and non-White patients. Among patients with high-risk myelodysplastic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback